blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0480717

EP0480717 - Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.02.1999
Database last updated on 31.08.2024
Most recent event   Tooltip19.02.1999No opposition filed within time limitpublished on 07.04.1999 [1999/14]
Applicant(s)For all designated states
MERCK FROSST CANADA INC.
16711 Trans-Canada Highway Kirkland
Quebec H9H 3L1 / CA
[N/P]
Former [1992/16]For all designated states
MERCK FROSST CANADA INC.
16711 Trans-Canada Highway
Kirkland Quebec H9H 3L1 / CA
Inventor(s)01 / Belley, Michel L.
5048 Woodland
Pierrefonds Quebec H8Z 2A2 / CA
02 / Leger, Serge
51 Rue Lamarche
Dollard des ormeaux H9B 2X4 / CA
03 / Roy, Patrick
11700 Pierrefonds Blvd.
Apt. 206B Pierrefonds H9A 2X2 / CA
04 / Xiang, Yi Bin
15407 Esterel
Pierrefonds H9H 1Y9 / CA
05 / Labelle, Marc
103 Rue Neuville
Ville d'Ile Perrot J7V 8L3 / CA
06 / Guay, Daniel
2684 Rozel
Montreal H3K 1T1 / CA
[1992/22]
Former [1992/16]01 / Belley, Michel L.
2005 Dutrisac No. 314
St. Laurent Quebec H4L 4K8 / CA
02 / Leger, Serge
51 Rue Lamarche
Dollard des ormeaux H9B 2X4 / CA
03 / Roy, Patrick
11700 Pierrefonds Blvd.
Apt. 206B Pierrefonds H9A 2X2 / CA
04 / Xiang, Yi Bin
15407 Esterel
Pierrefonds H9H 1Y9 / CA
05 / Labelle, Marc
103 Rue Neuville
Ville d'Ile Perrot J7V 8L3 / CA
06 / Guay, Daniel
2684 Rozel
Montreal H3K 1T1 / CA
Representative(s)Thompson, John, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
[N/P]
Former [1992/16]Thompson, John Dr., et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date91309306.810.10.1991
[1992/16]
Priority number, dateUS1990059688712.10.1990         Original published format: US 596887
US1991074188808.08.1991         Original published format: US 741888
[1992/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0480717
Date:15.04.1992
Language:EN
[1992/16]
Type: B1 Patent specification 
No.:EP0480717
Date:15.04.1998
Language:EN
[1998/16]
Search report(s)(Supplementary) European search report - dispatched on:EP07.02.1992
ClassificationIPC:C07D215/18
[1992/16]
CPC:
C07D215/18 (EP); C07D215/22 (KR); A61K31/44 (KR);
A61P11/00 (EP); A61P11/06 (EP); A61P11/10 (EP);
A61P13/02 (EP); A61P15/00 (EP); A61P27/02 (EP);
A61P27/14 (EP); A61P27/16 (EP); A61P29/00 (EP);
A61P29/02 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/00 (EP); C07D215/12 (EP); C07D215/24 (KR) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1992/16]
TitleGerman:Ungesättigte Hydroxyalkylchinolinsäuren als Leukotrien-Antagonisten[1998/16]
English:Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists[1992/16]
French:Acides hydroxyalkylquinoliniques insaturés comme antagonistes de leukotriène[1992/16]
Former [1992/16]Ungesättigte Hydroxyalkylchinolinsäuren zur Verwendung als Leukotrien-Antagonisten
Examination procedure08.09.1992Examination requested  [1992/45]
30.12.1994Despatch of a communication from the examining division (Time limit: M06)
27.06.1995Reply to a communication from the examining division
07.05.1996Despatch of a communication from the examining division (Time limit: M06)
05.11.1996Reply to a communication from the examining division
01.04.1997Despatch of a communication from the examining division (Time limit: M02)
30.05.1997Reply to a communication from the examining division
01.10.1997Despatch of communication of intention to grant (Approval: Yes)
13.02.1998Fee for grant paid
13.02.1998Fee for publishing/printing paid
20.02.1998Communication of intention to grant the patent
Opposition(s)16.01.1999No opposition filed within time limit [1999/14]
Fees paidRenewal fee
08.10.1993Renewal fee patent year 03
31.10.1994Renewal fee patent year 04
31.10.1995Renewal fee patent year 05
31.10.1996Renewal fee patent year 06
31.10.1997Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]EP0206751  (MERCK FROSST CANADA INC [CA]);
 [A]EP0233763  (MERCK FROSST CANADA INC [CA]);
 [A]EP0271287  (MERCK FROSST CANADA INC [CA]);
 [XD]EP0318093  (MERCK FROSST CANADA INC [CA]);
 [AD]US4851409  (YOUNG ROBERT N [CA], et al);
 [XPD]EP0399818  (MERCK FROSST CANADA INC [CA])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.